PETER KEORPES: Open Payments
NPI 1861622441 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,926 in 88 payments from 17 companies in 2025. Trend: 2023 $2,523 · 2024 $2,391 · 2025 $1,926
Food & beverage: $1,827Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $353 |
| Regeneron Healthcare Solutions, Inc. | 8 | $279 |
| Lilly USA, LLC | 8 | $226 |
| Incyte Corporation | 5 | $144 |
| PFIZER INC. | 8 | $135 |
| UCB, Inc. | 4 | $128 |
| Janssen Biotech, Inc. | 5 | $119 |
| LEO Pharma Inc. | 5 | $108 |
| Amgen Inc. | 4 | $105 |
| GENZYME CORPORATION | 3 | $100 |
Products named: DUPIXENT, EBGLYSS, RINVOQ, SKYRIZI, OPZELURA, Bimzelx, TREMFYA, CIBINQO.
Industry payments across IL — which companies pay providers there.
